Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
Novoyatleva et al investigate the role of receptor tyrosine kinase Axl in Pulmonary arterial hypertension (PAH), finding that the small molecule inhibitor R428 reduces human pulmonary arterial smooth muscle cells proliferation and migration, but causes toxicity in human pulmonary arterial endothelia...
Main Authors: | Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, Swathi Veeroju, Isabel Ben-Batalla, Paola Caruso, Mazen Shihan, Nadine Presser, Elsa Götz, Carina Lepper, Sebastian Herpel, Grégoire Manaud, Frédéric Perros, Henning Gall, Hossein Ardeschir Ghofrani, Norbert Weissmann, Friedrich Grimminger, John Wharton, Martin Wilkins, Paul D. Upton, Sonja Loges, Nicholas W. Morrell, Werner Seeger, Ralph T. Schermuly |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-021-02531-1 |
Similar Items
-
Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
by: Swathi Veeroju, et al.
Published: (2021-02-01) -
Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding
by: Nabham Rai, et al.
Published: (2018-01-01) -
Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”
by: Nabham Rai, et al.
Published: (2018-01-01) -
Genetic Delivery and Gene Therapy in Pulmonary Hypertension
by: Nabham Rai, et al.
Published: (2021-01-01) -
Effect of p53 activation on experimental right ventricular hypertrophy.
by: Swathi Veeroju, et al.
Published: (2020-01-01)